What Treats NMOSD Neuropathic Pain and Tonic Spasms?
At a Glance
NMOSD neuropathic pain and painful tonic spasms need different treatments: gabapentin or pregabalin and some antidepressants may help nerve pain, while carbamazepine or oxcarbazepine are commonly used for spasms. New or worsening symptoms need prompt evaluation because they may signal relapse.
In this answer
4 sections
Neuromyelitis optica spectrum disorder (NMOSD) can cause chronic symptoms that significantly impact your daily life. Two of the most challenging are neuropathic pain (ongoing burning or electrical nerve pain) and painful tonic spasms (sudden, intense muscle contractions) [1][2]. These symptoms often occur together, especially in the aftermath of a spinal cord attack (myelitis).
It is important to know that the medications and therapies discussed here are used to manage symptoms—they do not treat the underlying inflammation of NMOSD or prevent future attacks. You must continue your prescribed NMOSD disease-modifying treatments to prevent relapses, even if a pain medication makes you feel better.
Recognizing When to Get Urgent Help
Before adjusting any symptom medications, it is critical to determine if your pain or spasms mean something new is happening. Old NMOSD symptoms can temporarily flare up due to triggers like a fever, urinary tract infection (UTI), constipation, or medication changes. However, new or rapidly worsening spasms and pain can also be a sign of a new NMOSD attack (relapse) [3][4].
Because it is difficult to reliably tell the difference at home, prompt evaluation is essential. Early assessment is critical because treating an active relapse quickly—often with high-dose intravenous steroids, and sometimes plasma exchange (a procedure that filters harmful antibodies from your blood)—may limit lasting damage [4][5].
Go to the nearest emergency department and tell them you have NMOSD if you experience:
- Severe, new weakness in your arms or legs [4]
- Sudden vision loss or changes [6]
- Inability to walk or urinate [4]
- Difficulty breathing or swallowing [6]
- Persistent, uncontrollable hiccups or vomiting [6]
Managing Painful Tonic Spasms (PTS)
Painful tonic spasms (PTS) are brief, involuntary, and intensely painful muscle tightenings that usually last seconds to minutes. They can be triggered by movement, touch, or emotional stress, and commonly occur during recovery from a spinal cord attack [2][7].
- What to do during an episode: Try to sit or lie down safely to prevent a fall. Do not forcefully restrain or aggressively stretch the muscle during the spasm, as this can cause injury. Keep a brief diary of when the spasms occur, how long they last, and any triggers to share with your doctor.
- Sodium-channel blockers: To stop these spasms, specialists commonly use certain anti-seizure medications (like carbamazepine or oxcarbazepine) that block sodium channels in the nerves, helping to calm abnormal nerve signals [8]. While observational studies suggest these are often effective for NMOSD spasms, the evidence is limited and these drugs must be monitored carefully [8]. They can cause dizziness, sedation, low blood sodium, liver or blood-count issues, and rarely, severe blistering skin rashes [9][10].
- Alternatives: If these first-choice options are not tolerated, specialists may try other anti-seizure medications off-label, such as lacosamide, topiramate (which can have cognitive side effects), or eslicarbazepine [11][12][13].
- Muscle relaxants: Medications like baclofen may be used, particularly if you also have spasticity (constant, sustained muscle stiffness) [3].
Never start, stop, or change the dose of these medications without consulting your prescriber.
Managing Central Neuropathic (Burning) Pain
Central neuropathic pain results from damage to the spinal cord or brain and usually feels like a constant burning, aching, or “pins and needles” sensation [14]. The treatments for this ongoing nerve pain are different from those used for sudden spasms.
- Gabapentinoids: Medications like gabapentin and pregabalin are commonly recommended first-line options for general nerve pain [15]. They require careful dosing based on your kidney function [16]. Because they can cause significant dizziness and sleepiness, they can increase your risk of falls—especially if NMOSD has already affected your balance. They also carry a risk of respiratory (breathing) depression, particularly if combined with alcohol, opioids, or other sedating drugs [17]. Review all sedating medicines with your doctor, and avoid alcohol or driving until you know how the medication affects you.
- Antidepressants: Certain antidepressants, such as tricyclic antidepressants (TCAs) and serotonin-norepinephrine reuptake inhibitors (SNRIs, like duloxetine), are also considered first-line for nerve pain because they alter how the brain processes pain signals [15][18].
- Opioids and Tramadol: Strong opioids and tramadol are generally reserved as second- or third-line options due to their lower effectiveness for nerve pain, high risk of dependence, sedation, and potential to cause dangerous serotonin or respiratory interactions [15][19][20].
All of these medications must be tapered off slowly under medical supervision to avoid withdrawal or dangerous side effects [21].
Non-Pharmacological Treatments and Rehabilitation
Pain management in NMOSD usually requires a team approach combining medications with physical and psychological support [22].
- Individualized Rehabilitation: Working with a physical or occupational therapist who understands NMOSD is vital [23]. A therapist can provide a personalized plan for stretching, strengthening, and using assistive devices. Safe, tailored movement is important, as unsafe stretching or overexertion can accidentally trigger spasms or increase the risk of falls [24].
- Psychological Support: Living with unpredictable, severe pain and disability is frightening and exhausting, and it is completely normal to feel anxious or depressed [25][14]. Therapies like Acceptance and Commitment Therapy (ACT) can help you cope with the distress of chronic symptoms; seeking mental health support does not mean your pain is “in your head” [26].
- Scrambler Therapy: A small, preliminary trial in NMOSD investigated Scrambler therapy—an experimental treatment using patterned electrical stimulation on the skin—and found it reduced pain scores [27]. While more research is needed to prove its effectiveness and safety, it may be an option to discuss with a pain specialist.
Common questions in this guide
What medications are used for painful tonic spasms in NMOSD?
What treatments help NMOSD burning nerve pain?
Do pain medicines prevent NMOSD relapses?
Can worsening pain or spasms mean that NMOSD is relapsing?
When should someone with NMOSD pain go to the emergency room?
Are there nonmedication options for NMOSD pain and spasms?
What side effects should I monitor with NMOSD pain medicines?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on Neuromyelitis optica spectrum disorder.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What symptoms distinguish my painful tonic spasms from everyday muscle stiffness (spasticity)?
- 2.What baseline and follow-up blood tests (like kidney, liver, or sodium levels) do I need while taking these medications?
- 3.Can we create a written plan for what to do if my pain or spasms suddenly worsen?
- 4.Are any of my current medications interacting or compounding side effects like fatigue, dizziness, and fall risk?
- 5.Which specific red-flag symptoms should prompt me to go to the emergency room rather than waiting for an appointment?
- 6.Do any of these pain medications affect contraception, family planning, or pregnancy?
References
References (27)
- 1
Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis.
Hyun JW, Jang H, Yu J, et al.
Journal of clinical neurology (Seoul, Korea) 2020; (16(1)):124-130 doi:10.3988/jcn.2020.16.1.124.
PMID: 31942768 - 2
Paroxysmal painful tonic spasms in neuromyelitis optica spectrum disorder.
Lucas S, Lalive PH, Lascano AM
eNeurologicalSci 2023; (30()):100443 doi:10.1016/j.ensci.2023.100443.
PMID: 36698772 - 3
Neuromyelitis optica spectrum disorder with painful tonic spasms as the first symptom: a case report.
Zhao F, Wang Y, Gong J, et al.
Frontiers in medicine 2026; (13()):1814265 doi:10.3389/fmed.2026.1814265.
PMID: 42180759 - 4
Neuromyelitis optica spectrum disorders.
Huda S, Whittam D, Bhojak M, et al.
Clinical medicine (London, England) 2019; (19(2)):169-176 doi:10.7861/clinmedicine.19-2-169.
PMID: 30872305 - 5
Plasma Exchange for Neuromyelitis Optica Spectrum Disorders in Chinese Patients and Factors Predictive of Short-term Outcome.
Jiao Y, Cui L, Zhang W, et al.
Clinical therapeutics 2018; (40(4)):603-612 doi:10.1016/j.clinthera.2018.03.007.
PMID: 29606515 - 6
Central Sleep Apnea Syndrome Can Complicate Neuromyelitis Optica Spectrum Disorder: A Case Report.
Morelli C, Aeby A, Scaillet S, et al.
Frontiers in pediatrics 2020; (8()):547474 doi:10.3389/fped.2020.547474.
PMID: 33102404 - 7
Neuromyelitis optica: association with paroxysmal painful tonic spasms.
Carnero Contentti E, Leguizamón F, Hryb JP, et al.
Neurologia (Barcelona, Spain) 2016; (31(8)):511-5.
PMID: 25655945 - 8
Painful tonic spasm in neuromyelitis optica spectrum disorders: Prevalence, clinical implications and treatment options.
Liu J, Zhang Q, Lian Z, et al.
Multiple sclerosis and related disorders 2017; (17()):99-102 doi:10.1016/j.msard.2017.07.004.
PMID: 29055485 - 9
Cannabis extract for the treatment of painful tonic spasms in a patient with neuromyelitis optica spectrum disorder: A case report.
Tisavipat N, Siritho S, Prayoonwiwat N, Jitprapaikulsan J
Multiple sclerosis and related disorders 2020; (44()):102278 doi:10.1016/j.msard.2020.102278.
PMID: 32559701 - 10
Drug-Induced Lupus Erythematosus After 14 Years of Carbamazepine Use in a Patient With Neuromyelitis Optica Spectrum Disorder: A Case Report.
Ayuzawa-Takeda N, Saito K, Yanagida H, Oeda T
The American journal of case reports 2025; (26()):e949233 doi:10.12659/AJCR.949233.
PMID: 41411232 - 11
Neuromyelitis optica spectrum disorder related tonic spasms responsive to lacosamide.
Baheerathan A, Brownlee WJ, Rugg-Gunn F, et al.
Multiple sclerosis and related disorders 2017; (13()):73-74 doi:10.1016/j.msard.2017.02.009.
PMID: 28427706 - 12
Therapeutic effect of topiramate on paroxysmal tonic spasms in a Chinese woman with neuromyelitis optica spectrum disease: A case report.
Zhu J, Zhan S, Liang L
The journal of spinal cord medicine 2026; (49(5)):1171-1175 doi:10.1080/10790268.2025.2580122.
PMID: 41182195 - 13
Painful tonic spasms in a patient with neuromyelitis optica spectrum disorder: A case report.
Aryal R, Homagian S, Shrestha S, et al.
SAGE open medical case reports 2023; (11()):2050313X231167937 doi:10.1177/2050313X231167937.
PMID: 37122427 - 14
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients.
Ayzenberg I, Richter D, Henke E, et al.
Neurology(R) neuroimmunology & neuroinflammation 2021; (8(3)) doi:10.1212/NXI.0000000000000985.
PMID: 34108267 - 15
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.
Finnerup NB, Attal N, Haroutounian S, et al.
The Lancet. Neurology 2015; (14(2)):162-73.
PMID: 25575710 - 16
Higher-Dose Gabapentinoids and the Risk of Adverse Events in Older Adults With CKD: A Population-Based Cohort Study.
Muanda FT, Weir MA, Ahmadi F, et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2022; (80(1)):98-107.e1 doi:10.1053/j.ajkd.2021.11.007.
PMID: 34979160 - 17
Gabapentinoids in Chronic Kidney Disease: A Closer Look at Respiratory Risk.
Harven L, Alexander Paxton R, Giuliano C
The Annals of pharmacotherapy 2026; (60(8)):779-785 doi:10.1177/10600280251401899.
PMID: 41450155 - 18
Central neuropathic pain.
Rosner J, de Andrade DC, Davis KD, et al.
Nature reviews. Disease primers 2023; (9(1)):73 doi:10.1038/s41572-023-00484-9.
PMID: 38129427 - 19
Efficacy and safety of different drug treatments in patients with spinal-cord injury-related neuropathic pain: a network meta-analysis.
Mei L, Fengqun M, Zhengyao Z, et al.
Spinal cord 2022; (60(11)):943-953 doi:10.1038/s41393-022-00804-y.
PMID: 35468995 - 20
Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations.
Moisset X, Bouhassira D, Avez Couturier J, et al.
Revue neurologique 2020; (176(5)):325-352 doi:10.1016/j.neurol.2020.01.361.
PMID: 32276788 - 21
Gabapentinoid Pharmacology in the Context of Emerging Misuse Liability.
Evoy KE, Peckham AM, Covvey JR, Tidgewell KJ
Journal of clinical pharmacology 2021; (61 Suppl 2()):S89-S99 doi:10.1002/jcph.1833.
PMID: 34396549 - 22
Central Neuropathic Mechanisms in Pain Signaling Pathways: Current Evidence and Recommendations.
Viswanath O, Urits I, Burns J, et al.
Advances in therapy 2020; (37(5)):1946-1959 doi:10.1007/s12325-020-01334-w.
PMID: 32291648 - 23
Multidisciplinary rehabilitation for adults with neuromyelitis optica spectrum disorders: A pilot study.
Suo DM, Liu LL, Jia K, et al.
Journal of rehabilitation medicine 2019; (51(9)):692-697 doi:10.2340/16501977-2587.
PMID: 31418043 - 24
Longitudinally extensive transverse myelitis in childhood: Clinical features, treatment approaches, and long-term neurological outcomes.
Celik H, Aksoy E, Oztoprak U, et al.
Clinical neurology and neurosurgery 2021; (207()):106764 doi:10.1016/j.clineuro.2021.106764.
PMID: 34171586 - 25
Factors correlated with neuropathic pain in patients with neuromyelitis optica spectrum disorder.
Zhang X, Pei L, Xu Y, et al.
Multiple sclerosis and related disorders 2022; (68()):104213 doi:10.1016/j.msard.2022.104213.
PMID: 36223704 - 26
ACT with NMOSD: A targeted, telehealth-delivered mental health intervention for patients & caregivers.
Esiason DC, Smith PJ, Peppers CL, et al.
Multiple sclerosis and related disorders 2025; (102()):106630 doi:10.1016/j.msard.2025.106630.
PMID: 40716235 - 27
Scrambler therapy improves pain in neuromyelitis optica: A randomized controlled trial.
Mealy MA, Kozachik SL, Cook LJ, et al.
Neurology 2020; (94(18)):e1900-e1907 doi:10.1212/WNL.0000000000009370.
PMID: 32269109
This page is for informational purposes only and does not constitute medical advice. Ask your NMOSD specialist or prescriber before changing pain medicines, and seek urgent care for new or rapidly worsening symptoms.